Streetbeat News

Partnerships

SLG

SL Green Realty Corp. has signed a significant 10-year lease with Verition Group, increasing building occupancy to 92.5%. This lease adds to SL Green's total office leases signed this year, reaching over 3 million square feet.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 11:39 am

IPA

ImmunoPrecise Antibodies Ltd. (IPA) announced the publication of research led by Mayo Clinic scientists in bioRxiv and Autophagy. The study focuses on the development of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling, which is significant for cellular and tissue analysis.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 11:32 am

GILT

Gilat Satellite Networks Ltd. has secured a $4 million contract from the US Department of Defense for its DKET 3421 satcom terminals, enhancing global mission readiness. The contract is expected to be fulfilled by the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 11:08 am

MQ

Marqeta has launched Marqeta Flex, a new solution to simplify Buy Now, Pay Later (BNPL) options by integrating them directly into payment apps and wallets. This innovation is developed in collaboration with Klarna, Affirm, and Branch.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 11:07 am

GLUE

Monte Rosa Therapeutics shares rose following a global license agreement with Novartis to advance VAV1 MGDs. Monte Rosa will receive a $150 million upfront payment and potential milestone payments.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 11:03 am

PLUR

Pluri Inc. has secured funding from the Israel Innovation Authority for its collaboration with Bar-Ilan University to develop MAIT cell therapies targeting solid tumors. This partnership aims to enhance the efficacy of CAR-MAIT cell therapy using novel technologies.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 11:03 am

GLUE

Monte Rosa Therapeutics has entered into a global license agreement with Novartis to advance VAV1 MGDs. Monte Rosa will receive a $150 million upfront payment and is eligible for additional milestone payments.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 11:01 am

ORCL

PHR

Phreesia has achieved Oracle Validated Integration with Oracle Health EHR, enhancing patient experience and efficiency in healthcare. This integration allows healthcare organizations to improve operations and patient outcomes using Phreesia's tools.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 10:49 am

MRK

MRNA

Merck and Moderna have started a Phase 3 trial for V940 (mRNA-4157), an investigational therapy, in combination with Keytruda for certain non-small cell lung cancer patients.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 10:47 am

RVNC

Revance Therapeutics has entered into the sixth amendment of its exclusive distribution agreement with Teoxane, enhancing marketing and medical training efforts, and setting minimum purchase commitments through 2029.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 10:16 am